Ginkgo Bioworks: Declining Core Revenue And High Cash Burn Echo Amyris’ Path January 30, 2025 / DNA, Stephen Ayers / By mariocazombo76@gmail.com
Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug January 31, 2025 / Brendan O'Boyle, VRTX / By mariocazombo76@gmail.com